Rapid Communication
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2007; 13(48): 6575-6580
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6575
Table 4 Influence of SFAP on serum sIL-2R and Ig levels in cyclophosphamide-treated mice (mean ± SD)
GroupDose(mg/kg)sIL-2R (pmol/L)IgA(g/L)IgG(g/L)IgM(g/L)
NS control030.4 ± 2.52.92 ± 0.848.07 ± 0.942.31 ± 0.51
CTX control1077.8 ± 8.5b1.77 ± 0.14b6.35 ± 0.63b1.68 ± 0.14a
SFAP + CTX50 + 1075.9 ± 6.42.02 ± 0.316.87 ± 0.341.82 ± 0.27
SFAP + CTX100 + 1059.6 ± 6.1d2.31 ± 0.48c7.70 ± 0.37d2.16 ± 0.33d
SFAP + CTX200 + 1052.7 ± 5.7d3.11 ± 0.72d7.87 ± 0.59d2.49 ± 0.46d